News

Alembic Pharma’s Vadodara facility gets zero observations during USFDA inspection

The unannounced onsite USFDA bioequivalence inspection was conducted from 31st August, 2026 to 10th September, 2026

Alembic Pharmaceuticals Limited has reported successful completion of United States Food and Drug Administration (USFDA) onsite inspection at its Bioequivalence facility in Vadodara, Gujarat.

As per the company, its bioequivalence facility received no Form 483 observations.

The unannounced onsite USFDA bioequivalence inspection was conducted from 31st August, 2026 to 10th September, 2026.

Upcoming E-conference

ChemPharma R&D Summit 2026

October 27, 2026

Register Now

Other Related stories

IOL Chemicals Unveils Rs 495-crore expansion push across APIs, CDMO & specialty chemicals

Glenmark launches RYALTRIS to treat allergic rhinitis in Brazil

Lonza to build major commercial spray-drying facility in Oregon

Interviews

Targeting

Targeting Dual PIC/S and EU GMP accreditation to boost global standards: Chirag Doshi, Director, Yesh Medicare

We are set

We are setting up a plant in Uganda:Krushank Shah, Business Development Manager, S Kant Healthcare

Exploring

Exploring to expand into biological medicines through lab partnerships: Nikkhil K. Masurkar, CEO, Entod Pharmaceuticals

Appointments

Amitabh Dube appointed OPPI President

Amitabh Dube appointed OPPI President

Neurizon appoints Dr. Chris Bremer as CEO

Neurizon appoints Dr. Chris Bremer as CEO

Sachin Khode appointed Head of Marketing at Merck Healthcare

Sachin Khode appointed Head of Marketing at Merck Healthcare

Startup

BIRAC showcases India's biotech and assistive tech start-ups at Bharatiya Vyapar Mahotsav 2026

BIRAC showcases India's biotech and assistive tech start-ups at Bharatiya Vyapar Mahotsav 2026

Ayati Devices raises Rs. 15 Crore in pre-series A round led by Inflexor Ventures

Ayati Devices raises Rs. 15 Crore in pre-series A round led by Inflexor Ventures

CARPL.ai raises US$ 10 million in Series A led by IFC to scale global clinical AI platform

CARPL.ai raises US$ 10 million in Series A led by IFC to scale global clinical AI platform

Digitization

Sanofi signs three-year partnership with Tricog to scale AI-powered cardiac diagnostics

Sanofi signs three-year partnership with Tricog to scale AI-powered cardiac diagnostics

Medibyt secures FDA clearance for CPETWise digital health platform

Medibyt secures FDA clearance for CPETWise digital health platform

IIT Madras, CMC Vellore develop AI tools for early kidney disease detection

IIT Madras, CMC Vellore develop AI tools for early kidney disease detection

Upcoming Events

October 27, 2026 ChemPharma R&D Summit 2026

Latest Stories

Revvity to acquire human cell design in push to advance metabolic disease drug discovery

AstraZeneca’s Tozorakimab cuts COPD exacerbations by up to 34% in broad Phase III population

Brenntag and Indovinya strike exclusive European distribution deal for pharmaceutical excipients

IOL Chemicals Unveils Rs 495-crore expansion push across APIs, CDMO & specialty chemicals

Glenmark launches RYALTRIS to treat allergic rhinitis in Brazil

White Papers

Chasing Consistency: Centralizing operations data is the key to optimizing chemicals plants

Implementing a digital transformation in chemical operations to maximize profitability

The complexity of compliance

The Sprint to the Summit: Unlocking Lab Efficiency through Digital Transformation

The guiding role of fluidized and spouted bed technologies in particle building processes

Opinion

AI will redefine the future of precision medicine: Kalyan Kolachala, Managing Director, SymphonyAI Group India

AI will redefine the future of precision medicine: Kalyan Kolachala, Managing Director, SymphonyAI Group India

Transforming Indian healthcare innovation, investment, and patient-centric care: Nitin Thakur, Business Head, Meril Lifesciences

Transforming Indian healthcare innovation, investment, and patient-centric care: Nitin Thakur, Business Head, Meril Lifesciences

Interviews

Targeting Dual PIC/S and EU GMP accreditation to boost global standards: Chirag Doshi, Director, Yesh Medicare

Targeting Dual PIC/S and EU GMP accreditation to boost global standards: Chirag Doshi, Director, Yesh Medicare

We are setting up a plant in Uganda:Krushank Shah, Business Development Manager, S Kant Healthcare

We are setting up a plant in Uganda:Krushank Shah, Business Development Manager, S Kant Healthcare

Exploring to expand into biological medicines through lab partnerships: Nikkhil K. Masurkar, CEO, Entod Pharmaceuticals

Exploring to expand into biological medicines through lab partnerships: Nikkhil K. Masurkar, CEO, Entod Pharmaceuticals

Packaging

Amcor upgrades Illinois facility with advanced automation to bolster healthcare packaging safety

Amcor upgrades Illinois facility with advanced automation to bolster healthcare packaging safety

Amcor joins forces with Kelpi to push bio-based barrier coatings for fiber packaging

Amcor joins forces with Kelpi to push bio-based barrier coatings for fiber packaging

Clariant boosts high-speed packaging efficiency with expanded continuous strip desiccant reels

Clariant boosts high-speed packaging efficiency with expanded continuous strip desiccant reels